[go: up one dir, main page]

AU5691699A - Human genes differentially expressed in colorectal cancer - Google Patents

Human genes differentially expressed in colorectal cancer

Info

Publication number
AU5691699A
AU5691699A AU56916/99A AU5691699A AU5691699A AU 5691699 A AU5691699 A AU 5691699A AU 56916/99 A AU56916/99 A AU 56916/99A AU 5691699 A AU5691699 A AU 5691699A AU 5691699 A AU5691699 A AU 5691699A
Authority
AU
Australia
Prior art keywords
colorectal cancer
differentially expressed
human genes
genes differentially
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56916/99A
Inventor
Jon H. Astle
Christopher C. Burgess
Eddie Carroll Iii
Theodore J. Catino
Poornima Dwivedi
Wilson O. Endege
Donna M. Ford
Marcia E. Lewis
Gary A. Molino
John E. Monahan
Robert Schlegel
Kathleen E. Steinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of AU5691699A publication Critical patent/AU5691699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU56916/99A 1998-08-31 1999-08-30 Human genes differentially expressed in colorectal cancer Abandoned AU5691699A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9863998P 1998-08-31 1998-08-31
US60098639 1998-08-31
US11739399P 1999-01-27 1999-01-27
US60117393 1999-01-27
PCT/US1999/019424 WO2000012702A2 (en) 1998-08-31 1999-08-30 Human genes differentially expressed in colorectal cancer

Publications (1)

Publication Number Publication Date
AU5691699A true AU5691699A (en) 2000-03-21

Family

ID=26794949

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56916/99A Abandoned AU5691699A (en) 1998-08-31 1999-08-30 Human genes differentially expressed in colorectal cancer

Country Status (4)

Country Link
EP (1) EP1108021A2 (en)
JP (1) JP2002523088A (en)
AU (1) AU5691699A (en)
WO (1) WO2000012702A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1623993A3 (en) * 1999-09-01 2006-06-07 Genetech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6953658B2 (en) 2000-03-09 2005-10-11 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
US20010055596A1 (en) * 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer
AU2001250405A1 (en) * 2000-03-27 2001-10-08 Bayer Aktiengesellschaft Regulation of human adp-ribosylation factor-related protein
AU2001262133A1 (en) * 2000-03-27 2001-10-08 Bayer Aktiengesellschaft Regulation of human nedd1-related protein
AU2001263810A1 (en) * 2000-03-27 2001-10-08 Bayer Aktiengesellschaft Regulation of human c-myb-related genes
EP1272521A2 (en) * 2000-03-27 2003-01-08 Bayer Aktiengesellschaft Regulation of human oatp2-related protein
AU5623801A (en) * 2000-03-29 2001-10-08 Max Planck Gesellschaft 3d structure of polypeptides containing a tpr-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said peptides
EP1666491A1 (en) * 2000-06-02 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020110832A1 (en) * 2000-08-03 2002-08-15 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2001294999A1 (en) * 2000-08-07 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1330543A4 (en) * 2000-10-02 2006-03-29 Bayer Ag NUCLEIC ACID SEQUENCES DIFFERENTIALLY EXPRESSED IN CANCER TISSUE
US20020137038A1 (en) * 2000-12-04 2002-09-26 Lasek Amy W. Intestinal proteins
JP2004537534A (en) * 2001-06-20 2004-12-16 ジェネンテック・インコーポレーテッド Compositions and methods for tumor diagnosis and treatment
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030186302A1 (en) * 2002-03-29 2003-10-02 Yixin Wang Colorectal cancer diagnostics
AU2003296684A1 (en) 2002-12-20 2004-07-14 F. Hoffmann-La Roche Ag Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2004058153A2 (en) * 2002-12-20 2004-07-15 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
EP2311468B1 (en) 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gene overexpressed in cancer
DE10341812A1 (en) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
WO1995011923A1 (en) * 1993-10-29 1995-05-04 Dana-Farber Cancer Institute, Inc. A novel tumor marker and novel method of isolating same

Also Published As

Publication number Publication date
WO2000012702A2 (en) 2000-03-09
JP2002523088A (en) 2002-07-30
EP1108021A2 (en) 2001-06-20
WO2000012702A3 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
AU5691699A (en) Human genes differentially expressed in colorectal cancer
AU2001294943A1 (en) Nucleic acid sequences differentially expressed in cancer tissue
AU1922301A (en) Differential gene expression in cancer
AU1132595A (en) Chromosome 18q loss and prognosis in colorectal cancer
AU1344400A (en) Inflammation-associated genes
AU1453301A (en) Methods of reversing drug resistance in cancer cells
IL206604A0 (en) Transmembrane protein expressed in prostate cancer
AU2452197A (en) Genes amplified in cancer cells
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU5340699A (en) Human anion transporter genes atnov
AU2238499A (en) Androgen-metabolic gene mutations and prostate cancer risk
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU8026300A (en) Sodd gene expression in cancer
AU2001226922A1 (en) Cancer associated genes and their products
AU7089800A (en) 29 human cancer associated proteins
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU3549799A (en) Mammalian selenoprotein differentially expressed in tumor cells
AU9071098A (en) Breast cancer resistance genes, methods for their detection and uses thereof
AU2506499A (en) Cea/nca-based differentiation cancer therapy
AU5416700A (en) Differentially expressed genes in prostate cancer
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU2002324790A1 (en) Transmembrane protein differentially expressed in cancer
AU3349997A (en) Reg gene expression in cancer tissue
AU2001288940A1 (en) Gene and sequence variation associated with cancer
AU5474899A (en) Genes amplified in cancer cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase